Document Detail


Association analysis for neuronal nitric oxide synthase gene polymorphism with major depression and fluoxetine response.
MedLine Citation:
PMID:  12759556     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Nitric oxide (NO) is produced from its precursor L-arginine by the enzyme NO synthase (NOS), which includes at least three distinct isoforms - neuronal (nNOS), endothelial, and inducible NOS. Recent studies have implicated NOS in the mechanism that underlies the therapeutic efficacy of antidepressant medication. In addition, major depressive disorder (MDD) patients were found to have significantly higher plasma nitrate concentrations than normal subjects, an index of NO production, in comparison to normal subjects. In a population-based association study, we tested the hypothesis that the nNOS C276T polymorphism confers susceptibility to MDD. We also examined the association between this polymorphism and therapeutic fluoxetine response in 114 MDD patients who underwent a 4-week fluoxetine treatment. The results demonstrate that the nNOS variants are found at similar frequencies in MDD patients and healthy control subjects. Further, we did not discover any genetic variants that influenced the fluoxetine response in MDD patients treated with fluoxetine. Our findings suggest that this nNOS C276T polymorphism does not play a major role in the susceptibility to, or fluoxetine response in, MDD. However, the association between other NOS variants and MDD or antidepressant response, including sexual dysfunction, may warrant further investigation.
Authors:
Younger W-Y Yu; Tai-Jui Chen; Ying-Chieh Wang; Ying-Jay Liou; Chen-Jee Hong; Shih-Jen Tsai
Related Documents :
8205426 - Effect of mode of application of papaverine on the contractile response of the internal...
3661406 - Comparison of amplitude-modulated (direct) and frequency-modulated ambulatory technique...
2627766 - Accuracy of the ambulatory ecg monitoring system cardio-data mk4 in detecting exercise-...
11230836 - Effects of quinapril on clinical outcome after coronary artery bypass grafting (the quo...
15611036 - Cerebral ammonia uptake and accumulation during prolonged exercise in humans.
18680146 - Effect of exercise duration on the key pathways of ceramide metabolism in rat skeletal ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuropsychobiology     Volume:  47     ISSN:  0302-282X     ISO Abbreviation:  Neuropsychobiology     Publication Date:  2003  
Date Detail:
Created Date:  2003-05-21     Completed Date:  2003-07-03     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7512895     Medline TA:  Neuropsychobiology     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  137-40     Citation Subset:  IM    
Copyright Information:
Copyright 2003 S. Karger AG, Basel
Affiliation:
Yu's Psychiatric Clinic, Kaohsiung, Taipei, Taiwan, ROC.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antipsychotic Agents / therapeutic use*
Depressive Disorder, Major / drug therapy,  enzymology,  epidemiology
Female
Fluoxetine / therapeutic use*
Gene Expression / genetics*
Gene Frequency
Genotype
Humans
Incidence
Male
Middle Aged
Nitric Oxide Synthase / blood,  genetics*,  metabolism*
Nitric Oxide Synthase Type I
Polymerase Chain Reaction
Polymorphism, Genetic / genetics*
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 54910-89-3/Fluoxetine; EC 1.14.13.39/NOS1 protein, human; EC 1.14.13.39/Nitric Oxide Synthase; EC 1.14.13.39/Nitric Oxide Synthase Type I

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  VNTR polymorphism of tyrosine hydroxylase gene and schizophrenia in the Korean population.
Next Document:  Diffusion tensor magnetic resonance imaging of disruption of regional white matter in schizophrenia.